Literature DB >> 19931443

How often is diagnosis of COPD confirmed with spirometry?

Mats Arne1, Karin Lisspers, Björn Ställberg, Gunnar Boman, Hans Hedenström, Christer Janson, Margareta Emtner.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality worldwide. Diagnosis is customarily confirmed with spirometry, but there are few studies on documented spirometry use in everyday clinical practice.
METHODS: In a cross-sectional survey and study of the medical records of primary and secondary care COPD patients aged 18-75 in a Swedish region, patients with COPD were randomly selected from the registers of 56 primary care centres and 14 hospital outpatient clinics. Spirometry data at diagnosis +/-6 months were analyzed.
RESULTS: From 1114 patients with COPD, 533 with a new diagnosis of COPD during the four-year study period were identified. In 59% (n=316), spirometry data in connection with diagnosis were found in the medical records. Spirometry data with post-bronchodilator forced expiratory volume in 1s (FEV(1))/ vital capacity (VC) ratios were available in 45% (n=241). FEV1/VC ratio <0.70 were found in 160 patients, which corresponds to 30% of the patients with a new diagnosis. Lower age, female gender, current smoking, higher body mass index (BMI) and shorter forced exhalation time were related to COPD diagnosis despite an FEV(1)/VC ratio of >/=0.70. The most common problem in the quality assessment was an insufficient exhalation time.
CONCLUSIONS: Only a third of Swedish patients with COPD had their diagnosis confirmed with spirometry. Our data indicate that female gender, current smoking, higher BMI and short exhalation time increase the risk of being diagnosed with COPD without fulfilling the spirometric criteria for the disease. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 19931443     DOI: 10.1016/j.rmed.2009.10.023

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  56 in total

1.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD.

Authors:  Bridget F Collins; Laura C Feemster; Seppo T Rinne; David H Au
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

3.  Spirometry use among older adults with chronic obstructive pulmonary disease: 1999-2008.

Authors:  Shawn P E Nishi; Yue Wang; Yong-Fang Kuo; James S Goodwin; Gulshan Sharma
Journal:  Ann Am Thorac Soc       Date:  2013-12

Review 4.  Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.

Authors:  David B Price; Barbara P Yawn; Rupert C M Jones
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

5.  The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD.

Authors:  Josefin Sundh; Christer Janson; Karin Lisspers; Björn Ställberg; Scott Montgomery
Journal:  Prim Care Respir J       Date:  2012-09

6.  Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing.

Authors:  Andrea Gershon; Graham Mecredy; Ruth Croxford; Teresa To; Matthew B Stanbrook; Shawn D Aaron
Journal:  CMAJ       Date:  2016-11-14       Impact factor: 8.262

7.  Overuse and Misuse of Inhaled Corticosteroids Among Veterans with COPD: a Cross-sectional Study Evaluating Targets for De-implementation.

Authors:  Matthew F Griffith; Laura C Feemster; Steven B Zeliadt; Lucas M Donovan; Laura J Spece; Edmunds M Udris; David H Au
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

8.  Visual Assessment of CT Findings in Smokers With Nonobstructed Spirometric Abnormalities in The COPDGene® Study.

Authors:  Song Soo Kim; Kunihiro Yagihashi; Douglas S Stinson; Jordan A Zach; Alexander S McKenzie; Douglas Curran-Everett; Emily S Wan; Edwin K Silverman; James D Crapo; David A Lynch
Journal:  Chronic Obstr Pulm Dis       Date:  2014

9.  Clinical COPD Questionnaire score (CCQ) and mortality.

Authors:  Josefin Sundh; Christer Janson; Karin Lisspers; Scott Montgomery; Björn Ställberg
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-12-20

10.  Design, rationale, and baseline demographics of SEARCH I: a prospective cluster-randomized study.

Authors:  Frank Albers; Asif Shaikh; Ahmar Iqbal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.